MedTrace Logo

Evaluation of ClearLLab LS Screening Panel

NCT05819762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 831

Last updated 2024-12-04

No results posted yet for this study

Summary

This is a multi-center study to evaluate the clinical performance of ClearLLab LS screening panel with specimens from subjects for the diagnosis of hematologic malignancies.

Conditions

Interventions

DIAGNOSTIC_TEST

Flow Cytometry

Immunophenotyping of residual clinical samples tested with ClearLLab LS screening panel on a specified Flow Cytometry

Sponsors & Collaborators

  • Institute of Hematology & Blood Diseases Hospital, China

    collaborator OTHER

  • The First Affiliated Hospital of Soochow University

    collaborator OTHER

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • Beckman Coulter, Inc.

    lead INDUSTRY

Principal Investigators

  • China Clinical Affaris · Beckman Coulter, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-25
Primary Completion
2024-10-15
Completion
2024-11-18

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05819762 on ClinicalTrials.gov